Qi Xin, Hongxia Niu, Zhi Li, Guoping Zhang, Lina Hu, Bingxiang Wang, Jingjing Li, Hongjuan Yu, Wanbo Liu, Yue Wang, Zejiao Da, Ruiying Li, Qiaoyang Xian, Bingdong Zhu. Subunit Vaccine Consisting of Multi-Stage Antigens Has High Protective Efficacy against Mycobacterium tuberculosis Infection in Mice. PLOS ON. August 2013 | Volume 8 | Issue 8 | e72745
Ye L, Bao R, Guo M, Dai M, Rao Y, Zhang J, Wang Y, Xian QY, Huang Z-X, Wang X, Tang ZJ, Wang X, and Ho W-Z.: SIV infection of Chinese Rhesus Monkeys (Presented at 18th Scientific Conference of Society on NeuroImmune Pharmacology, Honolulu,HI, USA.April 24-28, 2012)
YongRong Zhang, Jian Liu, Yong Wang, QiaoYang Xian, LingYun Shao, Zhong Yang, XiaoNing Wang. Immunotherapy using IL-2 and GM-CSF is a potential treatment for multidrug-resistant Mycobacterium tuberculosis. Science China Life Sciences, September 2012, Volume 55, Issue 9, pp 800-806,
Wen Li, Huaqiong Huang, Wen Hu, Suqin Ben, Hui Liu, Bing Xu, Qiaoyang Xian, Zhijiao Tang, Huahao Shen. Neonatal revaccination with Bacillus Calmette–Guérin elicits improved, early protection against Mycobacterium tuberculosis in mice. Vaccine, Volume 30, Issue 21, 2 May 2012, Pages 3223–3230
Nguyen Van Luu, YANG Jiong, QU Xue-ju, GUO Ming, WANG Xin, XIAN Qiao-yang, TANG Zhi-jiao, HUANG Zhi-xiang , WANG Yong. Azithromycin inhibits neutrophil accumulation in airways by affecting interleukin-17 downstream signals. Chinese Medical Journal, 2012, Vol. 125 No. 3:491-495.
Li Q, Yu H, Zhang Y, Wang B, Jiang W, Da Z, Xian Q, Wang Y, Liu X, Zhu B. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice. Scand J Immunol. 2011 Feb 15.
Zhang J, Ye Y, Wang Y, Mo P, Xian Q, Rao Y, Bao R, Dai M, Liu J, Guo M, Wang X, Huang Z, Sun L, Tang Z*, Ho W*. M. tuberculosis H37Rv Infection of Chinese Rhesus Macaques. J Neuroimmune Pharmacol, 6: 363-370. 2011
Lu J, Yue J, Wu J, Luo R, Hu Z, Li J, Bai Y, Tang Z, Xian Q, Zhang X, Wang H.In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis. Pharmacology. 2010;85(6):365-71.
Luo Y, Wang B, Hu L, Yu H, Da Z, Jiang W, Song N, Qie Y, Wang H, Tang Z, Xian Q, Zhang Y, Zhu B. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice. Vaccine. 2009; 27(44):6179-85.